2014
DOI: 10.1016/j.jpba.2013.08.014
|View full text |Cite
|
Sign up to set email alerts
|

Metabolism studies of ifenprodil, a potent GluN2B receptor antagonist

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
27
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
10

Relationship

7
3

Authors

Journals

citations
Cited by 44 publications
(28 citation statements)
references
References 13 publications
0
27
0
Order By: Relevance
“…The concentration of ifenprodil used in the present study (4.16 mM) was higher than the IC50 for GluN2A containing NMDA receptors. There are mitigating factors to consider, such as the fact that the IC50s for ifenprodil were measured in Xenopus oocytes in vitro , or how far ifenprodil spread from the point of infusion thereby diluting it [102], as well as metabolic breakdown of ifenprodil in vivo after infusion took place [103] which would effectively lower the concentration of ifenprodil at neuronal synapses in AIC. While we met our goal of evaluating the differential effects of ifenprodil on behaviors and communication between control and PAE animals, the only way to be completely sure that the effects of ifenprodil were caused by inhibiting GluN2B-containing NMDA receptors will be to infuse a dose that is lower than the IC50 for GluN2A-containing NMDA receptors.…”
Section: Discussionmentioning
confidence: 99%
“…The concentration of ifenprodil used in the present study (4.16 mM) was higher than the IC50 for GluN2A containing NMDA receptors. There are mitigating factors to consider, such as the fact that the IC50s for ifenprodil were measured in Xenopus oocytes in vitro , or how far ifenprodil spread from the point of infusion thereby diluting it [102], as well as metabolic breakdown of ifenprodil in vivo after infusion took place [103] which would effectively lower the concentration of ifenprodil at neuronal synapses in AIC. While we met our goal of evaluating the differential effects of ifenprodil on behaviors and communication between control and PAE animals, the only way to be completely sure that the effects of ifenprodil were caused by inhibiting GluN2B-containing NMDA receptors will be to infuse a dose that is lower than the IC50 for GluN2A-containing NMDA receptors.…”
Section: Discussionmentioning
confidence: 99%
“…However,d ue to its low selectivity and bioavailability,t he clinical development of compound 1 was discontinued. [13] In 2011adimer of the ATDs of the GluN1ba nd GluN2B subunits wasc o-crystallized with 1 and Ro-25-6981 (2). [14] Unexpectedly, the binding site of the GluN2B-selective ligandsw as found at the interface between the GluN1b and GluN2B subunits instead solely within the GluN2B subunit.…”
Section: Introductionmentioning
confidence: 99%
“…14 However, the clinical development of 1 was terminated due to undesired side effects and low bioavailability. 15 Additionally, lack of selectivity of ifenprodil interacting with 5-HT 1A , 5-HT 2 , α 1 , σ 1 , and σ 2 receptors was observed.…”
Section: Introductionmentioning
confidence: 98%